Detergent-resistant Microdomains Determine the Localization of Sigma-1 Receptors to the Endoplasmic Reticulum-mitochondria Junction
Overview
Pharmacology
Authors
Affiliations
Sigma-1 receptors (Sig-1Rs) that bind diverse synthetic and endogenous compounds have been implicated in the pathophysiology of several human diseases such as drug addiction, depression, neurodegenerative disorders, pain-related disorders, and cancer. Sig-1Rs were identified recently as novel ligand-operated molecular chaperones. Although Sig-1Rs are predominantly expressed at endoplasmic reticulum (ER) subdomains apposing mitochondria [i.e., the mitochondria-associated ER membrane (MAM)], they dynamically change the cellular distribution, thus regulating both MAM-specific and plasma membrane proteins. However, what determines the location of Sig-1R at the MAM and how the receptor translocation is initiated is unknown. Here we report that the detergent-resistant membranes (DRMs) play an important role in anchoring Sig-1Rs to the MAM. The MAM, which is highly capable of accumulating ceramides, is enriched with both cholesterol and simple sphingolipids, thus forming Triton X-114-resistant DRMs. Sig-1Rs associate with MAM-derived DRMs but not with those from microsomes. A lipid overlay assay found that solubilized Sig-1Rs preferentially associate with simple sphingolipids such as ceramides. Disrupting DRMs by lowering cholesterol or inhibiting de novo synthesis of ceramides at the ER largely decreases Sig-1R at DRMs and causes translocation of Sig-1R from the MAM to ER cisternae. These findings suggest that the MAM, bearing cholesterol and ceramide-enriched microdomains at the ER, may use the microdomains to anchor Sig-1Rs to the location; thus, it serves to stage Sig-1R at ER-mitochondria junctions.
Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders.
Shokr M, Badawi G, Elshazly S, Zaki H, Mohamed A ACS Pharmacol Transl Sci. 2025; 8(1):47-65.
PMID: 39816800 PMC: 11729429. DOI: 10.1021/acsptsci.4c00564.
Sanchez-Sanchez L, Fernandez R, Astigarraga E, Barreda-Gomez G, Ganfornina M Anal Chem. 2024; 97(1):86-95.
PMID: 39718364 PMC: 11740170. DOI: 10.1021/acs.analchem.4c02421.
Mitochondrial dysfunction in Parkinson's disease.
Hattori N, Sato S J Neural Transm (Vienna). 2024; 131(12):1415-1428.
PMID: 39585446 DOI: 10.1007/s00702-024-02863-2.
Exploring the Role of Sigma Receptors in the Treatment of Cancer: A Narrative Review.
Fotakopoulos G, Gatos C, Georgakopoulou V, Christodoulidis G, Kagkouras I, Trakas N Cureus. 2024; 16(10):e70946.
PMID: 39502961 PMC: 11537387. DOI: 10.7759/cureus.70946.
Prokisch S, Buttner S Sci Rep. 2024; 14(1):13653.
PMID: 38871812 PMC: 11176346. DOI: 10.1038/s41598-024-64493-8.